A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice
Laura Lazo(Centro de Ingeniería Genética y Biotecnología), Lisset Hermida(Centro de Ingeniería Genética y Biotecnología), Iris Valdés(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Yaremis Romero(Centro de Ingeniería Genética y Biotecnología), María G. Guzmán(Universidad Complutense de Madrid), Carlos López, Lázaro Gil(Centro de Ingeniería Genética y Biotecnología), Aracelys Blanco(Centro de Ingeniería Genética y Biotecnología), Alequis Pavón(Instituto de Medicina Tropical “Pedro Kourí”)
Cited by 12
Related Papers
Dengue: a continuing global threat
|Nature Reviews Microbiology|2010|2.1k
Dengue infection
|Nature Reviews Disease Primers|2016|754
Evaluation of diagnostic tests: dengue
|Nature Reviews Microbiology|2010|588
Characteristics of Human Herpesvirus-6
|The Journal of Infectious Diseases|1988|293
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167